P

Pharmaniaga Bhd
KLSE:PHARMA

Watchlist Manager
Pharmaniaga Bhd
KLSE:PHARMA
Watchlist
Price: 0.285 MYR
Market Cap: 1.9B MYR

Wall Street
Price Targets

PHARMA Price Targets Summary
Pharmaniaga Bhd

Wall Street analysts forecast PHARMA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHARMA is 0.23 MYR with a low forecast of 0.152 MYR and a high forecast of 0.315 MYR.

Lowest
Price Target
0.152 MYR
47% Downside
Average
Price Target
0.23 MYR
19% Downside
Highest
Price Target
0.315 MYR
11% Upside
Pharmaniaga Bhd Competitors:
Price Targets
UPR
Uniphar PLC
34% Upside
NEU
Neuca SA
4% Downside
ILM1
Medios AG
57% Upside
2784
Alfresa Holdings Corp
7% Downside
UMC
UMediC Group Bhd
4% Upside
301015
Qingdao Baheal Medical Inc
0% Downside
GALE
Galenica AG
9% Downside

Revenue
Forecast

Revenue Estimate
Pharmaniaga Bhd

For the last 13 years the compound annual growth rate for Pharmaniaga Bhd's revenue is 7%. The projected CAGR for the next 3 years is 3%.

7%
Past Growth
3%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Pharmaniaga Bhd

For the last 13 years the compound annual growth rate for Pharmaniaga Bhd's operating income is 10%. The projected CAGR for the next 3 years is 5%.

10%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Pharmaniaga Bhd

For the last 13 years the compound annual growth rate for Pharmaniaga Bhd's net income is 7%. The projected CAGR for the next 3 years is 16%.

7%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-66%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHARMA's stock price target?
Price Target
0.23 MYR

According to Wall Street analysts, the average 1-year price target for PHARMA is 0.23 MYR with a low forecast of 0.152 MYR and a high forecast of 0.315 MYR.

What is Pharmaniaga Bhd's Revenue forecast?
Projected CAGR
3%

For the last 13 years the compound annual growth rate for Pharmaniaga Bhd's revenue is 7%. The projected CAGR for the next 3 years is 3%.

What is Pharmaniaga Bhd's Operating Income forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Pharmaniaga Bhd's operating income is 10%. The projected CAGR for the next 3 years is 5%.

What is Pharmaniaga Bhd's Net Income forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for Pharmaniaga Bhd's net income is 7%. The projected CAGR for the next 3 years is 16%.

Back to Top